Anthropic's Long-Term Benefit Trust Appoints Vas Narasimhan to Board of Directors

• Vas Narasimhan (Novartis CEO, physician-scientist) joins Anthropic board.
  • Overseen 35+ novel medicine approvals in heavily regulated industry.
  • Appointed by Long-Term Benefit Trust, not by shareholders.
• Trust-appointed directors now hold board majority at Anthropic.
  • Board: Dario Amodei, Daniela Amodei, Razavi, Kreps, Hastings, Liddell + Narasimhan.
• Appointment signals Anthropic’s healthcare/life-sciences deployment push.
• Trust mandate: balance stockholder returns against public benefit obligations.
  • Structural constraint rare among frontier AI labs — baked into governance.
• Narasimhan framing: AI accelerates drug discovery, disease understanding, medicine design.

Anthropic (official announcement) · ** · Read on anthropic.com